Paramstat Limited
Research and experimental development on biotechnology
Paramstat Limited contacts: address, phone, fax, email, website, shedule
Address: 75 New Street Ash CT3 2BL Canterbury
Phone: +44-1277 2991546
Fax: +44-1277 2991546
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Paramstat Limited"? - send email to us!
Registration data Paramstat Limited
Register date: 2011-12-16
Register number: 07884377
Type of company: Private Limited Company
Get full report form global database UK for Paramstat LimitedOwner, director, manager of Paramstat Limited
Gary Layton Director. Address: New Street, Ash, Canterbury, Kent, CT3 2BL, United Kingdom. DoB: March 1966, British
Dr Michael Oakes Director. Address: New Street, Ash, Canterbury, Kent, CT3 2BL, United Kingdom. DoB: June 1949, British
Jobs in Paramstat Limited vacancies. Career and practice on Paramstat Limited. Working and traineeship
Fabricator. From GBP 2500
Electrician. From GBP 1700
Electrical Supervisor. From GBP 1600
Project Co-ordinator. From GBP 1200
Welder. From GBP 1500
Responds for Paramstat Limited on FaceBook
Read more comments for Paramstat Limited. Leave a respond Paramstat Limited in social networks. Paramstat Limited on Facebook and Google+, LinkedIn, MySpaceAddress Paramstat Limited on google map
Paramstat has been operating in this business for 5 years. Registered under 07884377, it is registered as a Private Limited Company. You can reach the main office of the firm during office times under the following location: 75 New Street Ash, CT3 2BL Canterbury. The firm Standard Industrial Classification Code is 72110 : Research and experimental development on biotechnology. Paramstat Ltd reported its latest accounts up to 2015-12-31. The company's latest annual return information was submitted on 2015-12-16. Paramstat Ltd has been the leader in this particular field for the last five years.
This limited company owes its accomplishments and unending growth to a team of two directors, namely Gary Layton and Dr Michael Oakes, who have been controlling the firm since 2011.
